I. Solovic (Vysne Hagy, Slovakia), S. Winkler (Vienna, Austria)
An immunochromatographic rapid test not suitable for TB screening
E. Cojocaru, C. Cojocaru, I. L. Dumitriu, B. Gurzu (Iasi, Romania)
|  |
Screening for tuberculosis in candidates for immunosuppressive therapy
I. Gonçalves, D. Alves, F. Guedes, A. Carvalho, R. Duarte (Vila Nova de Gaia, Portugal)
| |
Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy
C. Sevinc, P. Mutlu, O. Kilinc, G. Can, N. Akkoc, E. S. Ucan (Izmir, Turkey)
| |
Tuberculosis in patients receiving anti-TNF-α treatment
L. Kawano-Dourado, L. Bezerra, M. Seiscento, F. Marinho, S. Bombarda, R. Sales (São Paulo, Brazil)
| |
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
M. L. Olleros, D. Vesin, A. F. Lambou, J. P. Janssens, B. Ryffel, V. F. Quesniaux, D. E. Szymkowski, I. Garcia (Geneva, Switzerland; Orleans, France; Monrovia, United States Of America)
| |
Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists
M. M. Aydin, S. Karaosman, Z. Gulbaran, T. Cagatay, Z. Kilicaslan (Istanbul, Turkey)
|  |
Organised local immune response in the lungs of patients with tuberculosis
G. Kosmiadi, G. Yevgushenko, T. Smirnova, T. Ulrichs, S. Kaufmann (Moscow, Russian Federation; Berlin, Germany)
| |
Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis
M. Aydin, T. Cagatay, S. Sunmez, Z. Gulbaran, P. Cagatay, S. Kamal, Z. Kilicaslan (Istanbul, Turkey)
| |
The impact of microRNAs on tuberculosis-induced tumor necrosis factor-α expression in monocytes/macrophages
C. Lo, C. Wang, K. Lee, H. Kuo (Taipei, Taiwan)
| |
An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans
B. Rybacka-Chabros, J. Milanowski (Lublin, Poland)
| |
Audit on the use of T spot test in the diagnosis of active tuberculosis in UHCW
B. Asuquo, N. Chandrappa (Coventry, United Kingdom)
| |
T spot TB reactivity – ²to treat or not to treat²
D. D‘Quino, A. Morris, J. Nash, B. Prathibha (Ashford, United Kingdom)
| |
Interferon gamma in pleural fluid for diagnosing tuberculosis. A comparison between 2 techniques: RIA and ELISA
R. M. Díaz Campos, V. Villena Garrido, M. D. Hisado Díaz, I. Escribano Gimeno, C. Vargas, A. López Encuentra (Madrid, Spain)
| |
Performance of a commercial whole blood interferon-gamma release assays in the management of pleural effusions
M. Losi, M. Bocchino, A. Matarese, R. D‘Amico, A. Sanduzzi, L. Fabbri, L. Richeldi (Modena, Naples, Italy)
| |
Adenosine deaminase activity in tuberculous and malignant pleural effusions
A. Garrouch, A. Smach, K. Limem, M. Benzarti (Sousse, Tunisia)
| |
Soluble receptor p55 a αTNF at the spread forms of pulmonary tuberculosis
L. Surkova, N. Shpakovskaya, A. Skrahina, J. Chalyj, S. Akalovich, O. Pashkova, A. Sholuh, N. Antonova, Z. Rohava (Minsk, Belarus)
| |
An association between polymorphism of genes responsible for Th1/Th2-polarization and tuberculosis in Russian population of Siberia
A. Rudko, A. An, E. Bragina, I. Saltikova, V. Puzyrev, M. Freidin (Tomsk, Russian Federation)
| |
Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence
L. Surkova, N. Shpakovskaya, A. Zalutskaya, A. Skrahina, Z. Rohava (Minsk, Belarus)
| |
Association between BCG scar and tuberculin skin test conversion
S. Fouzas, E. Skylogianni, D. Nikolaidis, K. Bolis, M. B. Anthracopoulos, S. Mantagos (Patras, Eleftheroupoli, Kavala, Greece)
| |
Lymphopenia and pulmonary tuberculosis
H. Racil, G. Laribi, S. Chikh Rouhou, O. Rkhis, N. Chaouech, M. Zarrouk, S. Yaalaoui, A. Chabbou (Ariana, Tunisia)
| |